Back to KROS
Connor, Clark & Lunn Investment Management Ltd. → KROS
Connor, Clark & Lunn Investment Management Ltd. KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$822K
Q3 2026
Peak value
$6.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.3M |
| Q4 2025 | $6.5M |
| Q1 2026 | $2.8M |
| Q2 2026 | $1.4M |
| Q3 2026 | $822K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $822K | 72.1K | — | — |
| Q2 2026 | $1.4M | 127.9K | — | — |
| Q1 2026 | $2.8M | 257.9K | — | — |
| Q4 2025 | $6.5M | 321.3K | — | — |
| Q3 2025 | $5.3M | 335.2K | — | — |